- Home
- HSCS vs NIVF Comparison
HSCS vs NIVF Comparison
Compare HSCS & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- NIVF
- Stock Information
- Founded
- HSCS 2007
- NIVF 2011
- Country
- HSCS United States
- NIVF Hong Kong
- Employees
- HSCS N/A
- NIVF N/A
- Industry
- HSCS Medical Specialities
- NIVF
- Sector
- HSCS Health Care
- NIVF
- Exchange
- HSCS Nasdaq
- NIVF NYSE
- Market Cap
- HSCS 3.2M
- NIVF 3.8M
- IPO Year
- HSCS 2022
- NIVF N/A
- Fundamental
- Price
- HSCS $3.17
- NIVF $0.12
- Analyst Decision
- HSCS Strong Buy
- NIVF
- Analyst Count
- HSCS 2
- NIVF 0
- Target Price
- HSCS $13.50
- NIVF N/A
- AVG Volume (30 Days)
- HSCS 15.1K
- NIVF 5.3M
- Earning Date
- HSCS 03-13-2025
- NIVF 02-16-2025
- Dividend Yield
- HSCS N/A
- NIVF N/A
- EPS Growth
- HSCS N/A
- NIVF N/A
- EPS
- HSCS N/A
- NIVF N/A
- Revenue
- HSCS $14,700.00
- NIVF $5,679,218.00
- Revenue This Year
- HSCS $174.19
- NIVF N/A
- Revenue Next Year
- HSCS $4,100.00
- NIVF N/A
- P/E Ratio
- HSCS N/A
- NIVF N/A
- Revenue Growth
- HSCS 151.28
- NIVF N/A
- 52 Week Low
- HSCS $2.36
- NIVF $0.11
- 52 Week High
- HSCS $18.50
- NIVF $17.24
- Technical
- Relative Strength Index (RSI)
- HSCS 39.08
- NIVF 25.20
- Support Level
- HSCS $3.11
- NIVF $0.11
- Resistance Level
- HSCS $3.45
- NIVF $0.29
- Average True Range (ATR)
- HSCS 0.17
- NIVF 0.03
- MACD
- HSCS -0.02
- NIVF -0.01
- Stochastic Oscillator
- HSCS 8.70
- NIVF 4.40
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.